Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2026-03-06 @ 3:03 AM
Study NCT ID:
NCT02734693
Status:
COMPLETED
Last Update Posted:
2020-03-27
First Post:
2016-04-01
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy and Safety of Dasotraline in Children 6 to 12 Years of Age With Attention-Deficit Hyperactivity Disorder (ADHD) in a Simulated Classroom Setting.
Sponsor:
Sumitomo Pharma America, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SEP360-305
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None